
The healthcare landscape in India is witnessing a technological revolution, and leading the charge is MedMitra AI, a health-tech startup leveraging artificial intelligence to enhance clinical decision-making. The company recently raised ₹3 crore in a pre-seed funding round, co-led by All In Capital and WEH Ventures, alongside notable angel investors, including Rohan Khandelwal, Pawan Gupta, and Venkat Subramanyam. This investment will fuel MedMitra AI’s mission to address critical inefficiencies in patient care through autonomous AI-driven solutions.
MedMitra AI integrates multimodal data, including patient history, lab results, prescriptions, and imaging—to assist doctors in diagnosis, treatment, and prognosis. By streamlining complex medical data, the startup aims to make healthcare more precise, efficient, and personalized. Initially focusing on general medicine and chronic care, MedMitra AI is tackling some of India’s most pressing healthcare challenges, including overburdened healthcare professionals and resource constraints.
Founded by Shivangi Sharma, an AI specialist, and Dr Anushka Sharma, a practising physician, MedMitra AI brings together medical expertise and technological innovation. Dr. Anushka’s experience as a physician has given her deep insights into the challenges doctors face in time-sensitive, high-pressure medical environments. Partnering with her sister Shivangi, who holds expertise in artificial intelligence from Northwestern University, the duo is committed to enhancing clinical workflows through AI-powered tools.
The startup has received strong backing from industry leaders. Kushal Bhagia, Founder of All In Capital, believes MedMitra AI can redefine doctor-patient interactions by optimizing the diagnostic process and making healthcare more accessible, particularly in underserved regions.
Similarly, Rohit Krishna, General Partner at WEH Ventures, emphasized the market demand for MedMitra AI’s platform. “During our discussions with doctors in Jaipur, we saw their enthusiasm for MedMitra’s technology and their readiness to adopt it in their practice. That convinced us of its real-world impact,” Krishna stated.
India’s AI-driven healthcare market is projected to reach $8.73 billion by 2030, growing at a CAGR of 41.8%. MedMitra AI’s innovative approach positions it as a key player in this evolving ecosystem, with its technology capable of reducing misdiagnoses, optimizing treatment plans, and improving overall healthcare delivery.
Also Read: HMH & Apollo’s Mega Partnership: Solving Workforce Gaps & Driving Innovation
As artificial intelligence continues to revolutionize industries, MedMitra AI stands out as a promising force in health-tech innovation. With a strong team, visionary leadership, and investor confidence, the startup is poised to make a meaningful impact in India’s healthcare sector.
With AI-driven diagnostics, MedMitra AI is not just building a product but reshaping the future of healthcare. The coming years will be crucial as the startup scales its operations and expands its technology to reach more hospitals, clinics, and healthcare professionals across India.
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.